18 वर्ष और उससे अधिक उम्र के वयस्कों में तेजी से बढ़ने वाले एलोपेशिया एरेटा (≥25% स्कैल्प) का उपचार

• It may be performed in adults with rapidly progressive S2 or higher initial-phase AA.
• Rapidly progressive AA patients with spontaneous cure tendency are excluded.
• Patients with a high possibility of spontaneous cure should be excluded.
• It may be performed in rapidly progressive S2 or higher initial-phase AA patients.
• Methylprednisolone at 500 mg/day was intravenously infused for three consecutive days in 139 patients with multiple AA, AT, or AU, and follow-up was performed for 6–70 months.
• As the recurrence rate after discontinuation is high, this therapy should be considered only in patients resistant to other standard treatments, such as corticosteroid application/injection.
• In another study, prednisolone at 40 mg/day was administered to 32 patients with a mean disease duration of 6.7 years for 1 week, and the dose was gradually decreased over 6 weeks.
• In 88% of patients with an alopecia area of ≤50% of the scalp within 6 months after the onset of alopecia, ≥75% hair recovery was achieved.

DOI: 10.14924/dermatol.134.2491